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ABSTRAK 
Tajuk: 
Perbandingan tahap penyakit mata yang kering (DES) dikalangan wanita putus 
haid yang menerima rawatan horrnon dan yang tidak menerima rawatan hormon di 
Hospital Universiti Sains Malaysia (HUSM). 
Pengenalan: 
Adalah menjadi pegetahuan umum bahawa Sindrom Mata Kering (DES) 
berlaku lebih kerap di kalangan wanita yang berusia berbanding lelaki. Wanita yang 
telah putus haid mempunyai kekurangan hormon yang mungkin menyumbang kepada 
DES. Oleh yang demikian, rawatan gantian hormon (HRT) dijangka akan menghalang 
berlakunya DES. Walaubagaimanapun, ia belum pemah dibuktikan secara saintifik. 
Objektif: 
Untuk menyiasat kejadian dan tahap keterukan DES di kalangan wanita putus 
haid di HUSM dan untuk membandingkan keputusan di antara wanita yang mengambil 
HRT dan yang tidak mengambil HRT. 
Tatacara: 
Wanita putus haid di HUSM menjalani pemeriksaan mata yang terdiri dari ujian 
Schirmer, masa rekahan air mata (BUT) dan pewama rose bengal. Sekurang-kurangnya 
2 ujian perlu didapati positif untuk memberikan diagnosis DES. Selepas pemeriksaan 
mata, darah pesakit diambil untuk menguji paras estradiol, progesterone dan 
dehydroepiandrosterone sulfate. 
XV 
Kcputusan: 
r .:m n p ulu l l c mpa( wan; la Ieiah d;peri ksa, cl i fllnlHl JO omnu (55.61%) menerimu 
rawatan hormon (kumpulan HRT) manakala 24 orang (44.4%) tidak mcncrima rawatan 
hom10n (kumpula n Kawa la n) . D i dalam k umpulan HRT, I I pesa kit me ne rima estrogen 
(kumpulan Estrogen) dan 19 pesakit menerima gabungan estrogen dan progesterone 
(kumpulan Gabungan) . Di ka langan pesakit di dalam kumpulan Kawalan, 29.2% 
d iu n pa ti m c mpu n ya i DES m a n t1k a la 70.0o/o pesuk:t dl dalam kumpu lan I II{T didapa t: 
mempunyai DES (p<0.05]. Perbandingan di antara pesakit yang mengambil rawatan 
harmon menunju kkan DES didapati lcb ih kerap di da lam kump ulan Gabunga n (84 .2%1) 
bcrbanding kumpulan Estrogen (45.5%) [p<0.05]. Apabila dikaji secara berasingan, 
ujian pengesanan DES yang ketara secara statistik hanyalah ujian BUT di antara 
kumpu\an Gabungan (94.7%) dan kumpulan Estrogen (45.5%) [p<0.05]. Perbezaan 
tahap keterukan DES di antara kumpulan-kumpulan tersebut didapati tidak ketara 
secara sa intifik. 
Kesimpulan: 
DES didapati lebih kerap berlaku di kalangan wanita putus haid yang 
mengambil HRT di HUSM. Rawatan gabungan estrogen dan progesterone didapati 
menyebabkan kejadian DES yang lebih tinggi berbanding rawatan menggunakan 
estrogen sahaja. Oleh itu, ini adalah bertentangan dengan anggapan bahawa HRT dapat 
menghalang DES. 
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ABSTRACT 
Title: 
A Comparative Study on the severity of Dry Eyes between menopausal women not 
on hormone replacement therapy (HRT) and those on HRT in HUSM. 
Introduction: 
It is a known fact that Dry Eye Syndrome (DES) occurs more commonly in females 
of older age group compared to men. Menopausal women have lack of hormones that may 
contribute to dry eye. Hormone replacement therapy, therefore, is expected to prevent the 
occurrence of dry eye. However, this has never been scientifically proven. 
Objective: 
To investigate the occurrence and severity of Dry Eye in menopausal women in 
HUSM and to compare the results between women taking hormone replacement therapy 
and those not taking any hormone replacement therapy. 
Methodology: 
Menopausal women tn HUSM underwent eye examination consisting of the 
Schirmer's test, the tear film breakup time and the rose bengal staining. At least 2 of the 
tests need to be abnormal to diagnose dry eye. After the ocular examination, blood was 
taken from every patient for estradiol, progesterone and dehydroepiandrosterone sulfate 
levels. 
XVll 
Results: 
Fifty-four women were examined, 30 (55.6°/o) of which were on honnone 
replacement therapy (HRT group), while 24 (44.4o/o) women were not on any honnone 
replacement therapy (control group). In the HRT group, 11 patients were on estrogen 
(Estrogen group) and 19 patients were on combined estrogen and progesterone (Combined 
group). Dry eye was found in 29.2% of patients in the control group and in 70.0% of 
patients in the HRT group [p<0.05]. Comparing the patients in the HRT group, dry eye 
occurred more frequently in the combined estrogen and progesterone group (84.2%) as 
compared to the estrogen only group (45.5%) [p<0.05]. When analysed separately, the 
only dry eye test found to be statistically significant was a positive BUT test between the 
Combined group (94.7%) and the Estrogen group (45.5°/o) [p<0.05]. The severity of dry 
eye was not statistically significant between groups. 
Conclusion: 
Dry eye was found more commonly in menopausal women who took hormone 
replacement therapy in Hospital Universiti Sains Malaysia. Combined estrogen and 
progesterone therapy was associated with a higher occurrence of dry eye compared to 
estrogen only therapy. These results, therefore, are in contrast to the previous assumption 
that HRT would prevent dry eye. 
INTRODUCTION 
1.1 BACKGROUND 
Keratoconjunctivitis sicca or 'dry eye' refers to a variety of disorders, which is 
characterized by ocular surface disease that results from any condition that decreases 
tear secretion or increases tear film evaporation sufficient to result in loss of water from 
the tear film (Gilbard, 1994). 
Although it may sound like a minor annoyance, dry eye is a potentially serious and 
chronic condition. It may severely limit a person's activity, and in extreme cases, cause 
blindness. Dry eye syndromes can be divided into aqueous deficient dry eye syndrome 
due primarily to a lack of tear secretion from the lacrimal gland, and evaporative dry 
eye syndrome typically caused by lipid insufficiency related to meibomian gland 
dysfunction. 
Dry eye commonly affects people in the older age group and is more common in 
women than men. Amongst the women with dry eye, it has been found to be commoner 
in menopausal women as compared to pre-menopausal women. Menopause is defined 
as the termination of the reproductive period of life in a woman, which is marked by 
the cessation of menstrual periods (Brudenell et. a/, 1992). Menstruation generally 
ceases between the ages of 45 and 55 with a median age of 51 in the United States, 
Europe and Asia (Purdie & Crawford, 1999). 
After menopause, the level of estrogen in the blood decreases. Kramer et. a/ in 
1990 had shown that the eye is a locus of action of female sexual hormones. Sator et. a/ 
( 1998) proposed the reduction of naturally occurring estrogen as a possible reason for 
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the occurrence of dry eye in menopausal women. According to a study done by Moss 
et. a/ in 2000, 14.4 °/o of the population involved in the Beaver Dam Eye Study was 
found to have dry eye. The age-adjusted prevalence in women was 16.7 °/o compared 
to 11.4 % in men (Moss et. al, 2000). 
The role of androgens in the pathophysiology of dry eye is increasingly being 
understood. Androgen appears to maintain an anti-inflammatory environment 
surrounding the lacrimal gland and keeps the functioning unit working properly. The 
lacrimal gland becomes more vulnerable to inflammation when the level of supportive 
androgen drops, as in menopausal women, aging men and women, autoimmune 
disease, complete androgen insensitivity syndrome (CAIS) and use of anti-androgen 
medications. The use of topical androgen for the treatment of dry eye is currently being 
studied. 
The methods used to diagnose dry eye includes subjective complaints and specific 
ocular examinations. The specific ocular examinations consist of measurement of tear 
quantity, tear quality, tear flow, tear film stability, and staining of devitalised and dead 
corneal epithelium. The measurement of tear quantity can be done by Schirmer's Test 
while Tear Mucus Feming can measure tear quality. Several methods can be used for 
estimation of tear flow, two of which are Tear Meniscus Dilution Test and 
Fluorophotometry. Another criterion for diagnosis of dry eye is the tear film stability 
and this is done by measuring the Tear Film Breakup Time or BUT. In addition to 
diagnosis, staining of the corneal epithelium with special dyes such as rose bengal, 
fluorescein or lissamine green allows grading of the severity of dry eye. 
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Dry eye treatment is geared towards reducing symptoms and inflammation, and 
maintaining a normal ocular surface. Tear substitutes are the most frequent medication 
prescribed for dry eye patients. The use of topical androgen as a treatment for lacrimal 
and meibomian gland dysfunction in androgen deficient individuals is currently being 
studied. Sator et. a/ in 1998 demonstrated that dry eye in menopausal women was 
successfully treated with the topical estrogen, 17P-oestradiol. 
As many menopausal women are receiving hormone replacement therapy for their 
symptoms, it is interesting to examine the relationship between dry eye and hormone 
replacement therapy (HRT). However, until now this is still poorly understood. This 
study aims to compare the severity of dry eye in menopausal women with regards to 
their HRT status and will hopefully give a better understanding of this relationship. 
1.2 THE NORMAL TEAR FILM 
The lacrimal reflex comprises of the lacrimal gland, conjunctiva, cornea and 
interconnecting innervation. This unit is known as the lacrimal functional unit (Zierhut 
et. a/, 2002). Tears support the normal structure and function of the corneal and 
conjunctival surfaces. It is the sum of the secretions of the many orbital glands and the 
epithelium that line the ocular surface. The result is a normal tear film that consists of a 
three-layered structure, namely the mucin, aqueous and lipid layer. This structure is 
remarkably stable and able to respond to the challenges of the environment to protect 
the ocular surface. Recently however, there is evidence for a two-layered structure 
consisting of a superficial lipid layer and an underlying aqueous-mucin gel, in which 
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the mucins have a decreasing gradient of concentration from the epithelium to the 
surface (Rolando & Zierhut, 2001 ). 
1.2.1 The Aqueous Layer 
Over ninety percent of the tear film thickness consists of the aqueous layer, which 
lies between the mucin and lipid layer. This layer is produced by the main and 
accessory lacrimal glands and measures 7J..Lm thick. The orbital and palpebral portion of 
the main lacrimal gland is thought to produce about 95°/o of tears while the rest comes 
from the accessory glands of Krause and Wolfring. The aqueous portion of the tears is 
secreted as an isotonic or slightly hypotonic solution. 
The aqueous tears flow from the ductule openings of the main and accessory 
lacrimal glands (in the superior fornix) into the forniceal spaces, the lacrimal rivers and 
over the exposed portion of the cornea and conjunctiva. The fluid is drawn into the two 
punctal openings in a relaxation phase immediately subsequent to a blink. The majority 
of tears are lost from the eye by flowing through the lacrimal drainage system via the 
superior and inferior canaliculi, the common canaliculus, the lacrimal sac, and the 
nasolacrimal duct, through the inferior meatus and into nasal cavity. However, a 
considerable amount of this fluid is reabsorbed across the mucosa of the superior and 
inferior canaliculi, the common canaliculus and the nasolacrimal duct during this 
passage. Some aqueous fluid is also lost through evaporation and reabsorption through 
the conjunctival surface. 
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Aqueous tear secretion diminishes under conditions of considerable decrease in 
external stimuli, such as general anaesthesia and during sleep. This fact supports the 
probability that aqueous tear secretion is stimulus driven at all times, and it is not 
possible to separate it into basal and reflex tear secretion (Lemp, 1992). 
1.2.2 The Lipid Layer 
The most superficial layer is the lipid layer, which is produced by the meibomian 
glands of the eyelids. This layer measures 0.1 Jlm thick. The lipid secreted by the 
meibomian gland is made up of a variety of lipid entities, including nonpolar sterol and 
waxy esters (around 58°/o), as well as other esters, free sterols, triglycerides and free 
fatty acids. About 15% of the meibomian gland secretion consists of polar lipids. 
The meibomian lipid is secreted as a fluid which flows onto the aqueous preocular 
tear film with the polar component spreading fastest. The charged polar groups of this 
component are oriented towards the aqueous phase. The nonpolar component spreads 
slowly and covers the polar layer to form a thicker duplex film. The lipid layer 
undergoes considerable compression and decompression during blinking but its high 
degree of stability allows it to resist deformation when subjected to high mechanical 
demands. 
There are at least three ways in which the stability of the tear film is enhanced by 
the lipid layer. Firstly, it tends to retard evaporation from the tear film. Secondly, 
meibomian gland secretion prevents contamination of the tear film by the more polar 
lipids secreted by the sebaceous glands of the eyelids, which tends to induce immediate 
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tear film breakup when applied to the eye. Finally, the lipid layer lowers the surface 
tension of the tears, which in turn draws water into the tear film, thickens the aqueous 
phase and allows it to spread evenly across the ocular surface (Lemp, 1992). 
1.2.3 The Mucin Layer 
The mucin layer is the layer adjacent to the corneal and conjunctival epithelium. It 
is the thinnest layer of the tear film and measures only 0.02J..lm to O.OSJ..lm thick. This 
layer consists mostly of mucous (hydrated) glycoprotein associated with a mixture of 
protein electrolytes and cellular material. The source of the mucin layer is from the 
conjunctival goblet cells, and the corneal and conjunctival epithelial cells (Rolando & 
Zierhut, 2001 ). The largest part of the mucinous content is produced by the goblet cells 
of the conjunctiva. These are unicellular, mucus-secreting glands scattered throughout 
the bulbar and palpebral conjunctiva. The highest density is at the inferior nasal 
palpebral conjunctiva. This distribution has been found to be similar in different age 
groups, with a slight decline in the seventh decade of life or older. 
Corneal epithelium is inherently hydrophobic due to the lipid content of the cell 
wall. Corneal and conjunctival epithelial cells secrete a glycoprotein forming an outer 
glycocalyx that is tightly bound to the epithelial cell surface. The mucin layer forms a 
loose adsorptive coating above this layer, which temporarily forms a new surface that is 
wettable by the overlying aqueous tear layer. The action of the lids adsorbs the mucin 
layer onto the corneal surface and this is thought to be a critical factor in establishing a 
new adsorbed layer over the corneal surface, which is wet by aqueous tears. In addition 
to increasing the affinity of tears for water, mucin also lowers the surface tension of 
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tears. Combination of these functions is thought to be sufficient to achieve complete 
wetting of the corneal surface (Lemp, 1992). 
1.3 TEAR FILM FUNCTION 
The term 'dry eye' is synonymous with 'Keratoconjunctivitis sicca' (KCS) and is 
often used interchangeably. However, more accurately, the term keratoconjunctivitis 
sicca is used for deficiency of the aqueous layer of the tear film. The National Eye 
Institute Workshop on clinical trials in dry eye had defined dry eye as a disorder of the 
tear film due to tear deficiency or excessive tear evaporation, which causes damage to 
the interpalpebral ocular surface and is associated with symptoms of ocular discomfort 
(Lemp, 1995). Several pre-ocular tear film functions are necessary for clear and 
comfortable vision. The pre-ocular tear film: 
· • Serves as the initial refracting surface of the eye 
• Serves as the primary route of oxygen supply to the anterior cornea 
• Provides the eye's antibacterial properties 
• Provides lubrication for the eyelids 
• Flushes away corneal metabolic waste products and other debris 
• Provides a means for white blood cells to reach the avascular cornea to 
assist in healing (Scott et. al, 1995) 
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1.4 EPIDEMIOLOGY OF DRY EYE 
The prevalence of dry eye increases with age and the condition occurs more 
commonly in women compared to men. Schein et. a/ in 1997 found that symptoms and 
signs of dry eye are common among a population-based sample of 2,520 elderly 
Americans. However, they found no association with age, sex or race. A study done by 
Moss et. al (2000) to estimate the prevalence of dry eye in a population of the Beaver 
Dam Eye Study showed that the overall prevalence of dry eye was 14.4 %. The age-
adjusted prevalence in women was 16.7 % compared to 11.4 o/o in men. They also 
found a significant difference in the prevalence of dry eye between subjects younger 
than 60 years (8.4o/o) and those older than 80 years ( 19.0%). Another study done in 
Melbourne by McCarty et. al in 1998 showed a lower prevalence of dry eye based on 
symptoms. This study found a prevalence of 5.5 °/o for severe dry eye symptoms and 
7.4 % for 2 or more symptoms of dry eye. 
l.SDRYEYESYNDROME 
Dry eye syndromes are of two major types: aqueous deficient dry eye syndrome, 
due primarily to a lack of tear secretion from the lacrimal gland, and evaporative dry 
eye syndrome, typically caused by lipid insufficiency related to meibomian gland 
dysfunction (Lemp, 1995). However, an aqueous deficiency often coexists with 
meibomian gland dysfunction, which may be a major factor in dry eye states, perhaps 
even more important than lacrimal gland dysfunction. In addition, the tear film 
responds to very delicate regulatory mechanisms involving neuroregulatory phenomena 
and hormonal stimulation (Baudouin, 2001 ). 
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The normal eye can become inflamed for a short time, perhaps from foreign body 
irritation or an infection, but it does not become chronic. However, if the level of 
supportive androgens drops, the lacrimal gland becomes more vulnerable to a "second 
hit," such as wind, low humidity or infection. This would produce rapid, chronic firing 
of the tear reflex that sets off inflammation within the lacrimal gland. T-cells norn1ally 
migrating through the gland become activated and synthesize and secrete pro-
inflammatory cytokines. These inhibit neurally induced tear secretion and cause 
inflammation to the ocular surface. In response to this inflammation, other circulating 
T-cells also migrate to the lacrimal gland. This promotes a chronic and self-
perpetuating inflammation, which can ultimately shut down production of aqueous by 
the lacrimal gland. 
Sullivan and Edwards ( 1997) tested the effect of androgen stimulation on lacrimal 
gland function in mouse models of Sjogren's syndrome. They found that androgen 
therapy enhances the functional activity of the lacrimal gland and causes a dramatic 
suppression of lacrimal gland inflammation in the mouse models. Androgens may also 
be involved in meibomian gland dysfunction. Human lacrimal glands, meibomian 
glands and other ocular tissues possess androgen receptors and the corresponding 
proteins. In a more recent study, Rocha et. a/, (2000) found androgen receptor proteins 
in human lacrimal gland, meibomian gland, cornea, bulbar and forniceal conjunctiva, 
lens epithelial cells and retinal pigment epithelial cell. Sullivan et. a/ (2000) found 
androgen receptor proteins within acinar epithelial cell nuclei of rat meibomian glands. 
Both studies suggest that the meibomian gland is an androgen target organ. In addition, 
Sullivan and co-workers tested the effects of androgen deficiency on rabbit meibomian 
gland. The results showed that androgen deficiency was associated with alterations in 
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the lipid content of the rabbit meibomian gland but did not appear to influence the gross 
morphology of the meibomian tissue or to exert a demonstrable effect on the rabbit tear 
film lipid layer. Therefore, androgens appear to stimulate meibomian gland cells to 
produce lipids, which maintain tear film stability and prevent tear film evaporation 
(Sullivan et. a/, 2000). 
Decreased androgen levels that occur during menopause, aging in men and women, 
autoimmune diseases such as Sjogren's syndrome, complete androgen insensitivity 
syndrome (CAIS), and use of antiandrogen medications for prostatic hypertrophy or 
cancer appear to correlate with the presence of meibomian gland dysfunction and 
evaporative dry eye. Androgen deficiency appears to promote the progression of 
autoimmune diseases, such as Sjogren's syndrome, and severe dry eye that develops. 
Moss et. a/ (2000) and Goebbles (2000) have found diabetic patients to be at 
higher risk of developing dry eye compared to general population. Moss et. al (2000) 
also studied other risk factors of dry eye in their study. They recruited 3 703 patients 
from the Beaver Dam Eye Study. The patients were subjected to a medical history 
questionnaire as well as a complete ocular examination. They found that arthritis and 
thyroid disease are among the medical conditions associated with dry eye. They also 
found medications such as aspirin, antidepressants and multivitamin to be significantly 
associated with the prevalence of dry eye in the same study. The use of angiotensin-
converting enzyme inhibitors, a- or (3-antiadrenergic agents, calcium channel blockers, 
diuretics, methyldopa, reserpine, parasympathetic agents, antihistamines, antianxiety 
agents and antiemetics, however, were not related to dry eye. 
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Although decreased production of basal tears is typically part of the aging process, 
concomitant stenosis of the punctae usually results in maintaining a normal relationship 
between tear secretion and elimination in older individuals. Even though they are free 
from dry eye symptoms, these patients often have epiphora from secondary reflex 
tearing (Patel et. al, 1990). However, others have consistent symptoms related to tear 
layer inadequacies. Mathers et. al ( 1996) have shown that there is a decline in tear flow 
function throughout life and when compared to previous studies, the tear flow is 
considerably less than previously estimated. 
1.6 MENOPAUSE AND DRY EYE 
The term menopause refers to the cessation of the menstrual period (Purdie & 
Crawford, 1999). It ranges between the ages of 48 to 52 years, with 51 years as the 
median age. Common transient symptoms of dry eye are vasomotor symptoms (such as 
hot flushes, night sweats and palpitations) and psychological symptoms (such as 
insomnia, poor memory, lost of confidence, mood changes, anxiety, loss of libido, 
diminished energy, difficulties in concentration and making decisions, irritability and 
crying spells). Perimenopausal and early postmenopausal women in Western 
industrialized countries commonly complain of these acute, transient symptoms. The 
long-term effects of estrogen withdrawal following menopause are more serious and 
include cardiovascular disease and osteoporosis. 
Menopause has also been associated with dry eye as lack of estrogen and 
progesterone causes reduced lacrimal secretion. This tear film deficiency results from 
progressive degeneration of the lacrimal glands due to postmenopausal hormone 
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deficiency and meibomian gland dysfunction during aging (Baudouin, 200 I). Kramer 
et. a/ in 1990 clearly showed that the conjunctiva is an estrogen sensitive epithelium. 
Their study showed that serum estrogen levels correlate with the maturation index of 
conjunctival epithelium and there is absence of cyclical changes in the conjunctival 
smears of postmenopausal women. Therefore, they suggested that estrogen deficiency 
might be of etiological importance in the pathogenesis of keratoconjunctivitis sicca. 
In addition, meibomian gland dysfunction may be linked to abnormal estrogen 
receptor activity. In a study done by Esmaeli et. a/ (2000), estrogen receptors were 
found to be present in the meibomian glands of the upper eyelid in humans. Modulation 
of the lipid layer of the tear film may involve the estrogen receptors and their activity 
may be linked to meibomian gland dysfunction and dry eye syndrome as well. 
Nevertheless, the relationship of sex hormones and dry eye, while long suspected, has 
not been defined in well-controlled studies. 
Data from the United States in 1995 showed that approximately 38% of post-
menopausal women in the United States used hormone replacement therapy (Keating 
et. a/, 1999). The most frequent indications for hormone replacement therapy are 
vasomotor symptoms and associated short-term signs. It was initially assumed that 
HRT would be beneficial to reduce the occurrence of dry eye in post-menopausal 
women. However, the exact relationship between HRT and dry eye is still poorly 
understood. 
Recent studies have shown that hormone replacement therapy should not be used 
for prevention of heart disease. The Women's Health Initiative (WHI) conducted a 
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study to investigate the risk and benefits of hormone use in healthy postmenopausal 
women (Writing Group, 2002). After 5.2 years of follow up, they found that the overall 
health risks exceeded the benefits from use of combined estrogen plus progestin and 
recommended that the regime should not be initiated or continued for primary 
prevention of coronary artery disease. Nelson et. a/ (2002) conducted a meta-analysis 
of eighteen observational studies and found that the benefits of using hormones include 
prevention of osteoporotic fractures and colorectal cancer, while the harmful effects 
includes coronary artery disease, stroke, thromboembolic events, breast cancer with 5 
or more years of use and cholecystitis. However, both the studies did not find an 
increased mortality in patients using hormone replacement therapy as compared to 
controls. 
1.7 DIAGNOSIS OF DRY EYE SYNDROME 
1.7.1 Subjective Complaints 
Patients with dry eyes frequently complain of pain, itching, sandy sensation, 
stickiness, or other irritative symptoms, but not necessarily of dry eye. Questionnaires 
have been formulated to assess dry eye symptoms. Among the available Dry Eye 
Questionnaires are the McMonnies Questionnaire and the Ocular Surface Disease Index 
Questionnaire (Schiffman et. al, 2000). Majority of the irritative symptoms suggest 
environmentally induced dry eye. Some examples include prolonged exposure to dry 
and smoky environments, after swimming in fresh chlorinated water, working in 'sick' 
buildings with abundance of fleecy materials, sites with inadequate dust exhausts 
' 
turpentine vapours and prolonged work with data processing machines. 
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Affective tearing where epiphora occurs in response to psychogenic weeping may 
be absent in patients with dry eye. Provoking tear secretion, for example by peeling 
onions, may also fail. An interesting phenomenon in patients with dry eye is called the 
paradoxical epiphora. This is most commonly seen in elderly patients with impaired 
tear secretion combined with reduced outflow of tears. These patients have age related 
atrophy of the lacrimal gland as well as impaired strength of the muscular fibres of the 
tear pump around the lacrimal sac or an abnormal nasolacrimal duct. Reflex stimulated 
tear secretion exceeds the reduced outflow of tears when these patients are out-doors, 
thus producing epiphora. When indoors, the nonstimulated tear secretion is minimal 
and the patient complains of dry eye. 
Therefore, subjective complaints seem to be of limited value in the diagnosis of 
dry eye. Although some authors regard symptoms as the most important method for 
detection of dry eye, there are still many dry eye patients who do not exhibit any 
symptoms. This necessitates the use for objective methods to diagnose dry eye. With 
regards to this, we have opted for the use of 3 dry eye tests in this study: the Schirmer's 
test, tear film stability breakup time (BUT) and rose bengal staining. 
1.7.2 Tear Quantity 
Tear production is measured per unit of time and is usually performed by 
absorption on filter paper. Schiffman et. al (2000) has shown that Schirmer's Tear Test 
correlates well with the patient's symptoms of dry eye. Whatman 's no. 41 filter paper is 
used to do the test. Its short folded end is inserted into the conjunctival sac of the lateral 
part of the lower eyelid and the reading is taken after 5 minutes (Nom, 1992). When 
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Schirmer initially described the test, measurement was preferred on an open eye. 
However, a closed eye method is more convenient for the patient and would be 
independent of blinking. Most authors prefer to do the Schirmers test using the closed 
eye method. The use of anesthesia may alter the results, thus this test should be 
performed without any topical anesthesia prior to any other test for dry eye. 
1. 7.3 Tear Flow 
A normal tear flow suggests that there is a proper relationship between tear 
production and tear outflow. Introduction of a dye or radioactive substance into the 
conjunctival sac followed by measurement of its concentration after a certain period 
allows tear flow to be assessed. Several methods can be used to measure tear flow such 
as the Tear Meniscus Dilution Test (using a mixture of rose bengal and fluorescein 
dye), scintigraphy (using saline solution containing technetium) and fluorophotometry 
(using fluorescein dye). 
1.7.4 Tear Quality 
When tears dry up on a glass slide, it forms fern-like crystals. If tear quality is poor 
from dry eye of different causes, crystallization is less pronounced. Tear Mucus 
Feming is a method to determine tear quality by observation of the crystallization of 
tears when it dries. 
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1.7.5 Tear Film Stability Breakup Time 
The Tear Film Breakup Time (BUT) measures the time taken for the first randomly 
distributed dry spot to appear after the patient's last blink, in an eye stained with 
fluorescein (Kanski, 1999). Vanley et. a/ in 1977 found that the BUT is not a closely 
reproducible phenomenon in an individual eye. Nevertheless, the BUT is a unique 
parameter for dry eye and cannot be replaced by other parameters. The BUT is 
independent of age, sex, size of palpebral fissure, ethnic origin, environmental 
temperature and moisture, although uncertain tendencies have been demonstrated 
(Nom, 1992). 
1.7.6 Mucus Tests 
A few dyes can be used to stain mucus thus allowing it to be assessed. Alcian blue 
alone or with tetrazolium can be used for this purpose. Alcian blue stains mucus 
specifically (chondroitin and mucoitin sulfate complexes stains blue) while neutrophilic 
leucocytes and mildly degenerated epithelial cells stains red with tetrazolium. 
Measurement of the mucous thread in the inferior fornix can also be done with alcian 
blue or rose bengal. The dimensions of the mucous thread are increased in patients with 
keratoconjunctivitis sicca, and when stained with rose bengal it appears to be thicker 
than normal. This is due to increased epithelial desquamation and abated mucous flow 
leading to accumulation of mucus in the inferior fornix. 
As mucus is produced by the goblet cells, determining the density of the goblet 
cells is clearly useful in diagnosing dry eye syndrome. The imprint technique is a non-
I 
I 
I 
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invasive method of determining goblet cell density and characteristically shows 
snakelike nuclear chromatin in keratoconjunctivitis sicca patients. Biopsy can also be 
easily performed for the same reason. 
1.7.7 Lipid Tests: Tear Film Interference 
A thin lipid layer superficially covers the preocular tear film, which prevents 
evaporation even on blinking. The thickness of this layer can be measured by using a 
slit lamp with an adjustable lamp (goose neck lamp) or merely by using the slit lamp 
alone. This test is interpreted by observation of the interference pattern of the lipid 
layer. In keratoconjunctivitis sicca, slower elimination of the tear film due to a 
diminished aqueous phase may increase the thickness of the lipid layer. On the other 
hand, some environmentally induced dry eye may lead to evaporation of the lipid layer 
into the atmosphere, therefore producing a thinner lipid layer on tear film interference. 
1.7.8 Staining 
Dry eye can be diagnosed with staining methods by demonstrating areas of 
dessication in the exposed region of the epithelium. The first reported ocular use of rose 
bengal was by Romer, Cobb and Lohle in 1914. In 1933, Henrik Sjogren introduced 
rose bengal for detection of keratoconjunctivitis sicca. Lissamine green and fluorescein 
stain have also been used to diagnose dry eye. Rose Bengal (4,5,6,7-tetrachloro-
2 ',4 ',5 ', 7' -tetraiodofluorescein sodium) belongs to the hydoxyxanthene group of dye. It 
is a fluorescein derivative and is the preferred stain for diagnosis of dry eye because it 
stains dead, degenerate and dessicated epithelial cells as well as mucus (Nom, 1992). In 
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addition, rose bengal also possess antibacterial, anti protozoal and antiviral properties 
(Roat et. a/, 1987). The only drawback is that rose bengal causes a smarting pain when 
instilled, while fluorescein and lissamine green do not. 
Feenstra & Tseng (1992a) showed that rose bengal staining could be blocked by 
tear components such as mucin and albumin. This suggests that normally negative rose 
bengal staining is due to the protective function of the preocular tear film and is not 
dictated by lack of cell vitality. In contrast to rose bengal, fluorescein lacks the ability 
to be blocked by mucin and albumin in tears (Feenstra & Tseng, 1992b). 
Van Bijsterveld in 1969 developed a scoring system for rose bengal dye. This 
grading is practical and universally accepted. It has proved invaluable in clinical studies 
and as a tool in quantitatively following up KCS patients. He reported that the scoring 
system has a sensitivity of 95% and a specificity of 96%. 
1.8 TREATMENT 
Dry eye treatment is geared towards reducing symptoms and inflammation, and 
maintaining a normal ocular surface. As dry eye conditions can exist without evidence 
of ocular surface damage (Lemp, 1995), the primary goal in treatment should be to 
improve symptoms. There are many causes of dry eye and therapy should be tailored 
towards the specific causes. Tear substitutes are the most frequent medication 
prescribed for dry eye patients. These so-called artificial tears usually contain 
methylcellulose in the form of hydroxyethylcellulose, hydroxypropylcellulose or 
hydroxypropylmethylcellulose. 
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The use of topical androgen as a treatment for lacrimal and meibomian gland 
dysfunction in androgen deficient individuals is currently being studied. However, the 
results of most clinical trials involving estrogen containing eye drops have been rather 
disappointing; with inconsistent improvement in tear film breakup time or Schirmer's 
test result. Vecsei et. al (2000) attempted to localize immunohistochemical estrogen 
and progesterone receptor staining in the human cornea. They found no nuclear 
immunohistochemical reaction in the epithelial and endothelial layers of the cornea. 
This shows no morphological basis in the human cornea for the use of topical steroid 
hormone therapy in postmenopausal women with keratoconjunctivitis sicca. On the 
other hand, a study by Sator et. al in 1998 demonstrated that dry eye in menopausal 
women was successfully treated with the topical estrogen, 1713-estradiol. They observed 
a statistically significant difference in ocular symptoms between patients receiving 1713-
estradiol and those receiving tear substitutes. In addition, the Schirmer's test revealed a 
significant difference before and after treatment in the estradiol group. The presence of 
estrogen receptors in the meibomian glands of the upper eyelid (Esmaeli et. al, 2000) 
may be linked to the success of topical estrogen therapy. 
Pharmaceutical treatment of dry eye includes mucolytic agents (eg. acetylcysteine), 
eye ointments as lubricants, vitamin A, tear production stimulants ( eg. bromhexine, 
eledoisin) and corticosteroids. In more severe dry eye, surgical treatment such as 
tarsorraphy, temporary or permanent occlusion of the lacrimal point, ectropionization 
of the lower lacrimal point or transposition of the parotid duct may be needed. When 
the eye is open, additional methods such as wearing tight-fitting goggles, moist 
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chambers, hot eye patches or spectacles with infusion pumps help to reduce the 
evaporation of the residual tear volume. 
OBJECTIVES 
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2. OBJECTIVES 
2.1 GENERAL OBJECTIVE 
The aim of this study is to compare the occurrence and severity of dry eyes m 
menopausal women on HRT and those not on HRT. 
2.2 SPECIFIC OBJECTIVES 
1. To compare the occurrence of dry eye among menopausal women on HRT 
and not on HRT in HUSM. 
2. To compare the severity of dry eye among menopausal women on HRT and 
not on HRT in HUSM. 
3. To compare the occurrence of dry eye between menopausal women on 
estrogen therapy and those on combined estrogen and progesterone therapy. 
4. To compare the severity of dry eye between menopausal women on 
estrogen therapy and those on combined estrogen and progesterone therapy. 
5. To investigate the association of estradiol, progesterone and 
dehydroepiandrosterone levels with the severity of dry eye. 
2.3 NULL HYPOTHESIS 
There is no difference in the severity of dry eye between menopausal women on 
hormone replacement therapy (HRT) and those not on HRT. 
MATERIALS 
AND 
METHODS 
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3. MATERIALS AND METHOD 
3.1 RESEARCH STRATEGY 
Comparative evaluation of dry eye severity between menopausal women on HRT and 
not on HRT. 
3.2 POPULATION, SETTING AND TIME 
Study population: 
1. Selected perimenopausal and menopausal women receiving HRT who attended the 
Menopause Clinic, HUSM during the period of study. 
2. Selected menopausal women not receiving HRT who attended the Eye Clinic, 
HUSM during the period of study. 
Period of study: 1st October 2001 to 1st October 2002 
Place of study: Ophthalmology Department, Hospital Kota Bharu. 
3.3 STUDY DESIGN 
This is a Clinical Cross-sectional study. 
3.4 SAMPLING AND SAMPLE SIZE 
3.4.1 Sampling method 
Non-probability Purposive Sampling 
3.4.2 Sample size calculation 
Sample size calculation (done by the Epi Info 6 Program)= 31 samples 
• Unmatched cross sectional study 
• Analysis by uncorrected chi-square test 
• Power of study: 80% 
• Confidence interval: 95% 
• Probability of exposure in controls: 16.7% (Moss et. al, 2000) 
• Probability of exposure in cases: 50% 
• Ratio of controls to case- 1:1 
Perimenopausal and menopausal women receiving HRT (Case) 
Estrogen only HRT = 15 samples 
Estrogen and Progesterone HRT = 16 samples 
Menopausal women not receiving HRT (Control) 
Total sample size 
= 31 
=J.l 
=62 
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